trimethylamine N-oxide TMAO
Selected indexed studies
- Trimethylamine N-Oxide (TMAO), Diet and Cardiovascular Disease. (Curr Atheroscler Rep, 2021) [PMID:33594574]
- The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer. (Cell Metab, 2022) [PMID:35278352]
- Trimethylamine N-Oxide (TMAO) and cancer risk: Insights into a possible link. (Biomed Pharmacother, 2025) [PMID:40987209]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Trimethylamine N-Oxide (TMAO), Diet and Cardiovascular Disease. (2021) pubmed
- The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer. (2022) pubmed
- Trimethylamine N-Oxide (TMAO) and cancer risk: Insights into a possible link. (2025) pubmed
- Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction. (2019) pubmed
- Emerging role of trimethylamine-N-oxide (TMAO) in colorectal cancer. (2021) pubmed
- Trimethylamine N-oxide (TMAO): a new attractive target to decrease cardiovascular risk. (2022) pubmed
- Microbiome-Derived Trimethylamine N-Oxide (TMAO) as a Multifaceted Biomarker in Cardiovascular Disease: Challenges and Opportunities. (2024) pubmed
- Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far? (2021) pubmed
- Trimethylamine N-oxide promotes PERK-mediated endothelial-mesenchymal transition and apoptosis thereby aggravates atherosclerosis. (2024) pubmed
- Gut Microbe-Generated Metabolite Trimethylamine-N-Oxide and Ischemic Stroke. (2024) pubmed